Global /United States /Healthcare /Drug Manufacturers - Specialty & Generic /BIEI
chevron_leftBack
Premier Biomedical, Inc. logo

Premier Biomedical, Inc.

BIEI
OTCMKTS: BIEI Delayed
0.0008USD -20%
As of 13 June 2026, Premier Biomedical, Inc. has a market cap of $1.49M USD, ranking #47789 globally and #6101 in the United States. It ranks #4238 in the Healthcare sector, and #332 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
47789
Country Rank
6101
Sector Rank
4238
Industry Rank
332
Key Stats
Market Cap
$1.49MUSD
Revenue (TTM)
$14.28KUSD
EBITDA (TTM)
-$323.91KUSD
Net Income (TTM)
-$374.47KUSD
PS Ratio
104.4
PB Ratio
-0.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
4
Founded
2010
Website
premierbiomedical.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-20% 60% 100% -20% 0% 60%

News

Loading...

Markets

Exchange Ticker Price
OTC Markets
MIC: OTCM
PRIMARY
BIEI
Premier Biomedical Inc
ISIN: US74048K2033
Shares Out.:
1.3B1 Shares Float: 1.269B2
TV:
SA:
YF:
GF:
BA:
MS:
0.0008 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Premier Biomedical, Inc.

Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer’s disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (United States)
Name
Market Cap diff.
PE
$29.56B
2M%
-
INDV
$2.07B
1.54B GBP
139K%
-
NDOI
$1.8B
121K%
0.4
$1.76B
118K%
-
$1.33B
89K%
-
$1.02B
69K%
12.1
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$36.75B
108.92B ILS
2M%
24.2
$15.84B
107.34B CNY
1M%
16.0
CIPLA
$11.16B
1.06T INR
748K%
23.4
LUPIN
$11.04B
1.05T INR
741K%
22.7
$9.09B
61.6B CNY
610K%
80.6
$8.74B
7.57B EUR
586K%
-
chevron_leftBack